GFG Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
8,443
+859
+11% +$238K 0.51% 42
2026
Q1
$2.24M Sell
7,584
-612
-7% -$182K 0.72% 35
2025
Q4
$2.24M Sell
8,196
-262
-3% -$71.2K 0.8% 30
2025
Q3
$2.29M Buy
8,458
+1,095
+15% +$298K 0.79% 35
2025
Q2
$2.03M Buy
+7,363
New +$2M 0.61% 44
2022
Q4
Sell
-6,197
Closed -$1.1M 123
2022
Q3
$1.1M Buy
6,197
+309
+5% +$61.1K 0.36% 39
2022
Q2
$1.21M Buy
5,888
+807
+16% +$171K 0.37% 38
2022
Q1
$1.18M Buy
+5,081
New +$1.19M 0.35% 47

Other funds holding CME

GFG Capital's CME Position: Q2 2026 in Review

GFG Capital increased its CME Group (CME) stake by 11% in Q2 2026, buying an estimated $238K and bringing the position to 8,443 shares worth $1.86M. The position accounts for 0.51% of the portfolio, ranked #42.

GFG Capital first reported a position in CME in Q1 2022 and has held it in 8 quarters since. The position peaked at $2.29M in Q3 2025. 308 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • GFG Capital held 8,443 shares of CME Group worth $1.86M as of Q2 2026.
  • GFG Capital bought 859 CME Group shares in Q2 2026, an estimated $238K.
  • CME Group made up 0.51% of GFG Capital's portfolio in Q2 2026, its #42 holding.
  • GFG Capital first reported a position in CME Group in Q1 2022 and has held it in 8 quarters since.
  • GFG Capital's CME Group position peaked at $2.29M in Q3 2025.
  • 308 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on GFG Capital's 13F filing for Q2 2026, filed 20 Jul 2026.